SPX Technologies
SPXC · NYSE
About SPXC
- Employees
- 4,700
- Headquarters
- Charlotte, North Carolina
- Listed
- Aug 2, 1972
- Sector
- Industrials
- Industry
- Machinery
- Website
- spx.com
SPXC key statistics
- Market cap
- 8.23B
- Price-earnings ratio
- 32.52
- Dividend yield
- —
- Average volume
- 650.48K
- Volume
- 466.40K
- Open price
- $164.24
- High today
- $167.32
- Low today
- $161.78
- 52 Week high
- $251.08
- 52 Week low
- $161.61
SPX Technologies (SPXC) at a glance
As of Oct 20, 2026, SPX Technologies (SPXC) shares are priced at $164.24, giving the company a market cap of 8.23B and a price-to-earnings ratio of 32.52.
Today the stock has traded between $161.78 and $167.32. The current price is 1.5% above the day's low and 1.8% below its high.
Volume so far is 466.40K shares, below the average of 650.48K shares a day.
Over the past year SPX Technologies has ranged from $161.61 to $251.08, and now sits 3% of the way up that range.
SPX Technologies met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $2.02 per share against an estimate of $1.88.
The average analyst price target is $278.62, 69.6% above the current price, from 11 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy90.9%
- Hold9.1%
- Sell0.0%
- Low
- $227.25
- Now
- $164.24
- High
- $325.50
SPXC earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 8.6% on average.
- Q3 FY24: reported $1.39 per share against an estimate of $1.38
- Q4 FY24: reported $1.51 per share against an estimate of $1.54
- Q1 FY25: reported $1.38 per share against an estimate of $1.20
- Q2 FY25: reported $1.65 per share against an estimate of $1.48
- Q3 FY25: reported $1.84 per share against an estimate of $1.65
- Q4 FY25: reported $1.88 per share against an estimate of $1.91
- Q1 FY26: reported $1.69 per share against an estimate of $1.60
- Q2 FY26: reported $2.02 per share against an estimate of $1.88
SPXC news
- Piero Cingari
- Evette Mitkov
SPX Technologies Stock Jumps After Surprising Q2 Results
- Press releaseGlobe Newswire
SPX Reports Second Quarter 2026 Results
- Press releaseGlobe Newswire
The Hidden Layer of the AI Boom: Robotics, Packaging Equipment Companies Are Thriving
- Press releaseGlobe Newswire
Taiwan Semiconductor Suppliers Are Moving to the US, Creating New Opportunities
- Press releaseGlobe Newswire
SPX Reports First Quarter 2026 Results
- Press releasePRNewswire
SPX Cooling Tech Unveils the Marley® OlympusMAX™ Fluid Cooler
- Press releaseGlobe Newswire
SPX Reports Fourth Quarter and Full-Year 2025 Results
Similar companies
Companies in the same industry as SPX Technologies
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.